Adopting facility designs that minimize the risk of contamination! Introducing the implemented systems as well.
We would like to introduce the case of CPC implementation at Kanazawa Medical University Hospital's Regenerative Medicine Center, which we have worked on. By introducing cleanliness management, room pressure management, and isolators, we adopted a facility design that minimizes the risk of contamination. The use of large windows between the management room and the cell preparation room creates a sense of openness and reduces stress for the operators. Additionally, the culture scenes can be viewed from outside the controlled area, allowing for active acceptance of visitors as an educational facility. The cell preparation room and supply room are equipped with airtight automatic doors, enabling smooth material handling. [Overview] - Introduction of cleanliness management, room pressure management, and isolators - Facility design that minimizes the risk of contamination - Large windows between the management room and the cell preparation room - Creates a sense of openness and reduces operator stress - Airtight automatic doors in the supply room for smooth material handling *For more details, please refer to the related links or feel free to contact us.
Inquire About This Product
basic information
【Introduced Systems】 ■Security System ■Environmental Monitoring System ■Cell Culture Process Management System ■Isolator System (Cell Processing Workstation) *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Implementation Results】 ■Kanazawa Medical University Hospital Regenerative Medicine Center *For more details, please refer to the related links or feel free to contact us.
Company information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.